Cite
HARVARD Citation
Takayama, K. et al. (2016). Randomized Phase II Study of Docetaxel plus Personalized Peptide Vaccination versus Docetaxel plus Placebo for Patients with Previously Treated Advanced Wild Type EGFR Non-Small-Cell Lung Cancer. Journal of immunology research. p. . [Online].